Expression of EGFP-amino-tagged human mu opioid receptor in Drosophila Schneider 2 cells: A potential expression system for large-scale production of G-protein coupled receptors

Protein Expression and Purification

Volumn 31, Issue 1, 2003, Pages 123-132

  Perret, Bénédicte G ^a   Wagner, Renaud ^a   Lecat, Sandra ^a   Brillet, Karl ^a   Rabut, Gwénaël ^b   Bucher, Bernard ^c   Pattus, Franc ^a  

^a CNRS   (France)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Fluorescence; G protein coupled receptor; Insect cells; Overexpression; Pharmacology

Indexed keywords

DROSOPHILA; INSECTA; MAMMALIA;

EID: 0141762594     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-5928(03)00140-2     Document Type: Article

References (23)

1. R.J. Bodnar, M.M. Hadjimarkou, Endogenous opiates and behavior: 2001, Peptides 23 (12) (2002) 2307-2365.
2. P.Y. Law, Y.H. Wong, H.H. Loh, Molecular mechanisms and regulation of opioid receptor signaling, Annu. Rev. Pharmacol. Toxicol. 40 (2000) 389-430.
3. L. Stanasila, D. Massotte, B.L. Kieffer, F. Pattus, Expression of delta, kappa and mu human opioid receptors in Escherichia coli and reconstitution of the high-affinity state for agonist with heterotrimeric G proteins, Eur. J. Biochem. 260 (2) (1999) 430-438.
4. D. Massotte, L. Baroche, F. Simonin, L. Yu, B. Kieffer, F. Pattus, Characterization of δ, κ and μ human opioid receptors overexpressed in baculovirus-infected insect cells, J. Biol. Chem. 272 (32) (1997) 19987-19992.
5. D. Massotte, C.A. Pereira, Y. Pouliquen, F. Pattus, Parameters influencing human mu opioid receptor over-expression in baculovirus-infected insect cells, J. Biotechnol. 69 (1) (1999) 39-45.
6. J. Kempf, L.A. Snook, J.L. Vonesch, T.E. Dahms, F. Pattus, D. Massotte, Expression of the human mu opioid receptor in a stable Sf9 cell line, J. Biotechnol. 95 (2) (2002) 181-187.
7. J. Benting, S. Lecat, D. Zacchetti, K. Simons, Protein expression in Drosophila Schneider cells, Anal. Biochem. 278 (1) (2000) 59-68.
8. K. Johanson, E. Appelbaum, M. Doyle, P. Hensley, B. Zhao, S.S. Abdel-Meguid, P. Young, R. Cook, S. Carr, R. Matico, et al., Binding interactions of human interleukin 5 with its receptor α subunit. Large scale production, structural, and functional studies of Drosophila-expressed recombinant proteins, J. Biol. Chem. 270 (16) (1995) 9459-9471.
9. A. Mestek, J.H. Hurley, L.S. Bye, A.D. Campbell, Y. Chen, M. Tian, J. Liu, H. Schulman, L. Yu, The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C, J. Neurosci. 15 (3 Pt 2) (1995) 2396-2406.
10. D.E. Keith, S.R. Murray, P.A. Zaki, P.C. Chu, D.V. Lissin, L. Kang, C.J. Evans, M. von Zastrow, Morphine activates opioid receptors without causing their rapid internalization, J. Biol. Chem. 271 (32) (1996) 19021-19024.
11. J.Y. Vollmer, P. Alix, A. Chollet, K. Takeda, J.L. Galzi, Subcellular compartmentalization of activation and desensitization of responses mediated by NK2 neurokinin receptors, J. Biol. Chem. 274 (53) (1999) 37915-37922.
12. B.P. Cormack, R.H. Valdivia, S. Falkow, FACS-optimized mutants of the green fluorescent protein (GFP), Gene 173 (1) (1996) 33-38.
13. I. Schneider, Cell lines derived from late embryonic stages of Drosophila melanogaster, J. Embryol. Exp. Morphol. 27 (2) (1972) 353-365.
14. K. Befort, L. Tabbara, S. Bausch, C. Chavkin, C. Evans, B. Kieffer, The conserved aspartate residue in the third putative transmembrane domain of the delta-opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site, Mol. Pharmacol. 49 (2) (1996) 216-223.
15. F. Talmont, S. Sidobre, P. Demange, A. Milon, L.J. Emorine, Expression and pharmacological characterization of the human mu-opioid receptor in the methylotrophic yeast Pichia pastoris, FEBS Lett. 394 (3) (1996) 268-272.
16. K. Befort, D. Filliol, F.M. Decaillot, C. Gaveriaux-Ruff, M.R. Hoehe, B.L. Kieffer, A single nucleotide polymorphic mutation in the human [micro]-opioid receptor severely impairs receptor signaling, J. Biol. Chem. 276 (5) (2001) 3130-3137.
17. C.K. Surratt, P.S. Johnson, A. Moriwaki, B.K. Seidleck, C.J. Blaschak, J.B. Wang, G.R. Uhl, Mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity, J. Biol. Chem. 269 (32) (1994) 20548-20553.
18. R. Schulz, A. Wehmeyer, K. Schulz, J. Murphy, Effect of phosducin on opioid receptor function, J. Pharmacol. Exp. Ther. 289 (1) (1999) 599-606.
19. N.I. Tarasova, R.H. Stauber, J.K. Choi, E.A. Hudson, G. Czerwinski, J.L. Miller, G.N. Pavlakis, C.J. Michejda, S.A. Wank, Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A, J. Biol. Chem. 272 (23) (1997) 14817-14824.
20. C. Weill, B. Ilien, M. Goeldner, J.L. Galzi, Fluorescent muscarinic EGFP-hM1 chimeric receptors: design, ligand binding and functional properties, J. Recept. Signal Transduct. Res. 19 (1-4) (1999) 423-436.
21. V. Sarramegna, F. Talmont, M. Seree de Roch, A. Milon, P. Demange, Green fluorescent protein as a reporter of human muopioid receptor overexpression and localization in the methylotrophic yeast Pichia pastoris, J. Biotechnol. 99 (1) (2002) 23.
22. V. Sarramegna, P. Demange, A. Milon, F. Talmont, Optimizing functional versus total expression of the human mu-opioid receptor in Pichia pastoris, Protein Expr. Purif. 24 (2) (2002) 212-220.
23. M.R. Tota, L. Xu, A. Sirotina, C.D. Strader, M.P. Graziano, Interaction of [fluorescein-Trp25]glucagon with the human glucagon receptor expressed in Drosophila Schneider 2 cells, J. Biol. Chem. 270 (44) (1995) 26466-26472.